EAGLE PHARMACEUTICALS, INC. Quarterly Income Tax Expense (Benefit) in USD from Q1 2013 to Q2 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
Summary
Eagle Pharmaceuticals, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from Q1 2013 to Q2 2023.
  • Eagle Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the quarter ending June 30, 2023 was $4.13M, a 15.4% increase year-over-year.
  • Eagle Pharmaceuticals, Inc. Income Tax Expense (Benefit) for the twelve months ending June 30, 2023 was $17.2M, a 1.96% decline year-over-year.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2022 was $25.8M, a 532% increase from 2021.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2021 was $4.08M, a 61.8% decline from 2020.
  • Eagle Pharmaceuticals, Inc. annual Income Tax Expense (Benefit) for 2020 was $10.7M, a 39.1% increase from 2019.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2023 $17.2M $4.13M +$552K +15.4% Apr 1, 2023 Jun 30, 2023 10-Q/A 2023-08-09
Q1 2023 $16.7M $4.48M -$9.12M -67.1% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $25.8M $5.14M -$2.28M -30.7% Oct 1, 2022 Dec 31, 2022 10-K 2023-03-23
Q3 2022 $28.1M $3.47M +$10.5M Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $17.6M $3.58M +$1.65M +85% Apr 1, 2022 Jun 30, 2022 10-Q/A 2023-08-09
Q1 2022 $15.9M $13.6M +$11.8M +672% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $4.08M $7.42M +$4.09M +123% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-23
Q3 2021 -$11K -$7.04M -$8.9M -477% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $8.89M $1.94M -$3.69M -65.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 $12.6M $1.76M +$1.9M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $10.7M $3.33M +$977K +41.5% Oct 1, 2020 Dec 31, 2020 10-K 2023-03-23
Q3 2020 $9.71M $1.87M +$2.02M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-09
Q2 2020 $7.69M $5.63M +$3.15M +127% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-09
Q1 2020 $4.54M -$137K -$3.14M -105% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-10
Q4 2019 $7.69M $2.35M -$289K -10.9% Oct 1, 2019 Dec 31, 2019 10-K 2022-03-08
Q3 2019 $7.97M -$152K -$3.78M -104% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-02
Q2 2019 $11.8M $2.48M +$5.66M Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-10
Q1 2019 $6.1M $3M +$3.96M Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q4 2018 $2.14M $2.64M +$1.79M +209% Oct 1, 2018 Dec 31, 2018 10-K 2021-03-05
Q3 2018 $347K $3.63M -$5.4M -59.8% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-12
Q2 2018 $5.75M -$3.18M -$4.55M -331% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-08
Q1 2018 $10.3M -$959K -$10.7M -110% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-07
Q4 2017 $21M $854K +$29.9M Oct 1, 2017 Dec 31, 2017 10-K 2020-03-02
Q3 2017 -$8.86M $9.03M +$8.65M +2282% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-01
Q2 2017 -$17.5M $1.37M +$789K +135% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-07
Q1 2017 -$18.3M $9.75M +$9.73M +51205% Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q4 2016 -$28M -$29M Oct 1, 2016 Dec 31, 2016 10-K 2019-02-28
Q3 2016 $379K +$597K Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-08
Q2 2016 $584K +$737K Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-09
Q1 2016 $19K -$380K -95.2% Jan 1, 2016 Mar 31, 2016 10-Q 2017-05-08
Q3 2015 -$1.03M -$218K -$218K Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 -$813K -$153K -$153K Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 -$660K $399K +$1.69M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q4 2014 -$2.35M -$1.06M -$1.06M Oct 1, 2014 Dec 31, 2014 10-K 2017-03-15
Q3 2014 -$1.3M $0 Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-12
Q2 2014 $0 $0 Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-11
Q1 2014 -$1.3M -$1.3M Jan 1, 2014 Mar 31, 2014 10-Q 2015-05-15
Q4 2013 $0 Oct 1, 2013 Dec 31, 2013 10-K 2017-03-15
Q2 2013 $0 Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $0 Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-15
* An asterisk sign (*) next to the value indicates that the value is likely invalid.